Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 11, 2021, 11:05 pm
SANTA MONICA, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three and nine months ended September 30,
